TPL
Company Details
Linkedin ID:
torrent-pharmaceuticals-ltd
Website:
Employees number:
11,324
Number of followers:
326,789
NAICS:
3254
Industry Type:
Homepage:
torrentpharma.com
IP Addresses:
0
Company ID:
TOR_9330091
Scan Status:
In-progress
Torrent Pharmaceuticals Ltd Company CyberSecurity Posture
torrentpharma.com
Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”
Torrent Pharmaceuticals Ltd A.I CyberSecurity Scoring
TPL Risk Score (AI oriented)Between 750 and 799
TPL
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
TPL Global Score (TPRM)XXXX
TPL
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
TPL Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
TPL Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for TPL
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Torrent Pharmaceuticals Ltd in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Torrent Pharmaceuticals Ltd in 2025.
Incident Types TPL vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Torrent Pharmaceuticals Ltd in 2025.
Incident History — TPL (X = Date, Y = Severity)
TPL cyber incidents detection timeline including parent company and subsidiaries
TPL Company Subsidiaries
Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”
Loading...
TPL Similar Companies
MANKIND PHARMA LTD
Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing,
Fresenius Kabi
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portf
UCB
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine
At Teva, we're proud to be a different kind of global pharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, our commitment to bettering health has never wavered. Every day, we challenge ourselves to p
Merck Group
This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trad
Grifols
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions i
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the pa
The Janssen Pharmaceutical Companies of Johnson & Johnson
At Janssen, we never stop working toward a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep working tirelessly to make that future a reality for patients everywhere, by fighting sickness with science, improving ac
At Lonza, we enable A Healthier World by supporting our healthcare customers on the path to commercialization. Our community of 16,000 talented employees work across a global network of more than 30 sites to deliver for our customers across the pharma, biotech and nutrition markets. By combining t
.png)
TPL CyberSecurity News
September 10, 2025 07:00 AM
Stocks to Watch: Torrent Pharma, RVNL, Eicher Motors and more
Torrent Pharma, Eicher Motors, Jupiter Wagons, and Tega Industries, which announced strategic acquisitions, GST benefit transfers,...
August 18, 2025 07:00 AM
Matt DeFrain rejoins MorganFranklin Cyber to head healthcare and life sciences
Matt DeFrain has rejoined MorganFranklin Cyber, a Charlotte, NC-based cybersecurity consulting and managed services firm,...
August 03, 2025 07:00 AM
Senores Pharma appoints Sanjay Moralwar as Head of IT
Ahmedabad: Senores Pharma has announced the appointment of Sanjay Moralwar as Head of Information Technology.\"Excited to welcome Mr. Sanjay...
April 03, 2025 07:00 AM
India's generic medicines steal the spotlight as US exempts pharma from tariffs
India's pharma sector has emerged as a big winner amid Trump's tariff woes, as the US has exempted pharmaceuticals from reciprocal tariffs,...
February 04, 2025 08:00 AM
Sigachi Industries establishes state-of-the-art R&D Center in Hyderabad
Sigachi Industries is establishing a state-of-the-art R&D Center in Hyderabad to enhance its Research and Development (R&D) capabilities.
October 30, 2024 07:00 AM
Torrent Pharmaceuticals Promoter Sells 2.9% Stake for Rs 3,086 Crore
Torrent Investments, a promoter entity of Torrent Pharmaceuticals, has sold a 2.9% stake in the company for Rs 3086 crore through open...
October 17, 2022 07:00 AM
After Ipca Laboratories, pharma major Aarti Drugs hit by ransomware attack; data leaked on dark web
Leaked data (Aarti Drugs: 6 GB; Ipca Laboratories: 140 GB) includes employee records, formulation and research data, and financial and audit...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
TPL CyberSecurity History Information
Official Website of Torrent Pharmaceuticals Ltd
The official website of Torrent Pharmaceuticals Ltd is http://www.torrentpharma.com.
Torrent Pharmaceuticals Ltd’s AI-Generated Cybersecurity Score
According to Rankiteo, Torrent Pharmaceuticals Ltd’s AI-generated cybersecurity score is 788, reflecting their Fair security posture.
How many security badges does Torrent Pharmaceuticals Ltd’ have ?
According to Rankiteo, Torrent Pharmaceuticals Ltd currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Torrent Pharmaceuticals Ltd have SOC 2 Type 1 certification ?
According to Rankiteo, Torrent Pharmaceuticals Ltd is not certified under SOC 2 Type 1.
Does Torrent Pharmaceuticals Ltd have SOC 2 Type 2 certification ?
According to Rankiteo, Torrent Pharmaceuticals Ltd does not hold a SOC 2 Type 2 certification.
Does Torrent Pharmaceuticals Ltd comply with GDPR ?
According to Rankiteo, Torrent Pharmaceuticals Ltd is not listed as GDPR compliant.
Does Torrent Pharmaceuticals Ltd have PCI DSS certification ?
According to Rankiteo, Torrent Pharmaceuticals Ltd does not currently maintain PCI DSS compliance.
Does Torrent Pharmaceuticals Ltd comply with HIPAA ?
According to Rankiteo, Torrent Pharmaceuticals Ltd is not compliant with HIPAA regulations.
Does Torrent Pharmaceuticals Ltd have ISO 27001 certification ?
According to Rankiteo,Torrent Pharmaceuticals Ltd is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd employs approximately 11,324 people worldwide.
Subsidiaries Owned by Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd presently has no subsidiaries across any sectors.
Torrent Pharmaceuticals Ltd’s LinkedIn Followers
Torrent Pharmaceuticals Ltd’s official LinkedIn profile has approximately 326,789 followers.
NAICS Classification of Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Torrent Pharmaceuticals Ltd’s Presence on Crunchbase
No, Torrent Pharmaceuticals Ltd does not have a profile on Crunchbase.
Torrent Pharmaceuticals Ltd’s Presence on LinkedIn
Yes, Torrent Pharmaceuticals Ltd maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/torrent-pharmaceuticals-ltd.
Cybersecurity Incidents Involving Torrent Pharmaceuticals Ltd
As of December 11, 2025, Rankiteo reports that Torrent Pharmaceuticals Ltd has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Torrent Pharmaceuticals Ltd has an estimated 5,413 peer or competitor companies worldwide.
Torrent Pharmaceuticals Ltd CyberSecurity History Information
How many cyber incidents has Torrent Pharmaceuticals Ltd faced ?
Total Incidents: According to Rankiteo, Torrent Pharmaceuticals Ltd has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Torrent Pharmaceuticals Ltd ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.
Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=torrent-pharmaceuticals-ltd' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
